Michael Grant, MD, explores how clinicians can overcome real-world barriers to molecular testing in resected NSCLC.

Shiven B. Patel, MD, MBA, discussed strategies for overcoming tissue limits, delays, and rural access gaps in NSCLC biomarker testing at an IVBM event.

Soft biological tissues are important constituents that influence human physiology and disease since they impact cell behavior during tissue development, maintenance and repair. Most existing methods ...

A new study highlights the potential of whole genome and transcriptome sequencing (WGTS) to improve precision treatment and identify the tissue of origin for cancers whose primary site is unknown, ...

Integrating plasma next-generation sequencing (NGS) alongside tissue testing when determining lung cancer diagnosis may improve outcomes for patients. Carrying out plasma next-generation sequencing ...

The FDA has cracked down on the use of power morcellators in recent years. The devices are used in gynecological and general laparoscopic procedures to break up uterine fibroids and other tissue ...

Diagnosis requires a tissue biopsy for histopathologic and immunohistochemistry evaluation. Testing for alterations using non-small cell lung cancer (NSCLC) tumor tissue requires acquisition of a ...

An ultrasound is one of several tests that can help confirm a soft tissue sarcoma diagnosis. Ultrasounds create detailed images showing the size and location of tumors. These images can also be used ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Animal testing could slowly be replaced with experiments using ...

The "Short-read Transpore Rapid Karyotyping," or "STORK" for short, is an inexpensive rapid test created by Columbia University researchers that is able to accurately detect genetic disorders in a ...

LAKE FOREST, Calif. & WOODLAND PARK, N.J.--(BUSINESS WIRE)--Summit Health, part of Village MD and Genomic Testing Cooperative (GTC), the global leader in RNA innovation, are excited to announce today ...